[Metastatic malignant pheochromocytoma: treatment with alpha-methyl-para-tyrosine].
D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000188:drug therapy*; D000328:Adult; D001859:Bone Neoplasms; D002395:Catecholamines / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000209:etiology; D007674:Kidney Diseases / Q000209:etiology; D008113:Liver Neoplasms; D008781:Methyltyrosines / Q000009:adverse effects / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D009392:Nephrectomy; D010673:Pheochromocytoma / Q000150:complications / Q000188:drug therapy*; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors; D014642:Vanilmandelic Acid / Q000652:urine; D014682:Vena Cava, Inferior
D002395:Catecholamines; D008781:Methyltyrosines; D014642:Vanilmandelic Acid; D014446:Tyrosine 3-Monooxygenase
Phéochromocytome malin métastasé: traitement par l'alpha-méthyl-para-tyrosine.